Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 10:26 PM
NCT ID:
NCT03211858
Pre Assignment Details:
Randomization was stratified by HbA1c at screening visit (\<8%, greater than or equal to \[\>=\] 8%), prior use of NovoLog/NovoRapid (Yes, No), geographical region (Europe, United States \[US\], Japan) and type 1 or 2 of diabetes mellitus (T1DM/T2DM \[US only\]). Assigned to arms in 1:1 ratio (SAR341402: NovoLog/NovoRapid).
Recruitment Details:
The study was conducted at 82 centers in 7 countries. A total of 846 participants were screened between 02 August 2017 and 29 December 2017, of which 249 participants were screen failures. Screen failures were mainly due to glycated hemoglobin A1c (HbA1c) level lesser than (\<) 7.0% or greater than (\>) 10% at the screening visit.
Study:
NCT03211858
Study Brief:
Results Section:
NCT03211858